Membrane technology

DuPont Selected to Provide Membrane Technology to Sorek B, Israel's Largest Desalination Plant

Retrieved on: 
Tuesday, July 27, 2021

WILMINGTON, Del., July 27, 2021 /PRNewswire-PRWeb/ -- DuPont (NYSE:DD) today announced that its FilmTec membranes have been selected by IDE Water Technologies to provide the sea water reverse osmosis (SWRO) filtration for the Sorek B desalination plant in Israel.

Key Points: 
  • WILMINGTON, Del., July 27, 2021 /PRNewswire-PRWeb/ -- DuPont (NYSE:DD) today announced that its FilmTec membranes have been selected by IDE Water Technologies to provide the sea water reverse osmosis (SWRO) filtration for the Sorek B desalination plant in Israel.
  • The 25-year, 200 million m3/year facility, which will be the largest desalination plant in Israel and one of the largest in the world, is predicted to set a new benchmark for seawater desalination water prices on a global scale.
  • DuPont is providing SWRO membrane elements to the project site, including dry SWRO elements.
  • The largest of its kind reverse osmosis plant will be built in Sorek central Israel, and will increase Israel's desalination capacity by 35 percent.

Insights Extracorporeal Membrane Oxygenation Machine Global Market to 2025 - Miniaturization of ECMO Machines Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021

The "Global Extracorporeal Membrane Oxygenation Machine Market (2020-2025) by Components, Modality, Application, Patient Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Extracorporeal Membrane Oxygenation Machine Market (2020-2025) by Components, Modality, Application, Patient Type, End-User, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
  • The Global Extracorporeal Membrane Oxygenation Machine Market is estimated to be USD 295.3 Mn in 2020 and is expected to reach USD 467.2 Mn by 2025, growing at a CAGR of 9.6%.
  • The Global Extracorporeal Membrane Oxygenation Machine Market is segmented further based on Components, Modality, Application, Patient Type, End-User, and Geography.
  • The report offers a comprehensive evaluation of the Global Extracorporeal Membrane Oxygenation Machine Market.

Worldwide Gas Separation Membrane Industry to 2028 - Featuring Schlumberger, DIC & Ube Industries Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021

Recent advancements in the petrochemical industries has led to an increased use of membranes for gas separation.

Key Points: 
  • Recent advancements in the petrochemical industries has led to an increased use of membranes for gas separation.
  • A variety of membrane materials have been used for gas separation such as polymer, zeolite, silica, and others.
  • Market players are focusing on launch of products, which is expected to strengthen their position in the global gas separation membrane market.
  • For instance, in 2018, Evonik Industries AG, a German chemical company launched SEPURAN NG membrane to enable efficient processing of natural gas.

Outset Medical to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

Retrieved on: 
Thursday, July 22, 2021

Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2021 after the close of trading on Thursday, August 5, 2021.
  • The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Thursday, August 5, 2021.
  • A live and archived webcast of the event will be available on the Investors section of the Outset website at https://investors.outsetmedical.com/ .
  • Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

Spectral Medical Inc. Announces $10 Million Offering

Retrieved on: 
Wednesday, July 21, 2021

TORONTO, July 21, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the “Company”) is pleased to announce that further to its previously announced overnight marketed public offering of units of the Company (the “Units”), Paradigm Capital Inc. (the “Lead Underwriter”) and A.G.P./Alliance Global Partners, the exclusive U.S. placement agent for the Offering (together, the “Underwriters”), have agreed to purchase on a bought deal basis 23,530,000 Units at a price of $0.425 per Unit (the “Issue Price”) for aggregate gross proceeds of $10 million (the “Offering”).

Key Points: 
  • If the Over-Allotment Option is exercised in full, the total gross proceeds to the Company will be $11,500,288.
  • Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of proprietary platforms addressing renal replacement therapy (RRT) across the dialysis spectrum.
  • While these assumptions were considered reasonable by Spectral at the time of preparation, they may prove to be incorrect.
  • Certain assumptions with respect to the Offering include those relating to the filling of the prospectus supplement, completion of the Offering in a timely manner and the ability to obtain all necessary regulatory approvals in connection with the Offering.

Spectral Medical Inc. Announces Overnight Marketed Offering

Retrieved on: 
Tuesday, July 20, 2021

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

Key Points: 
  • TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (Spectral or the Company) is pleased to announce the launch of a proposed overnight marketed public offering of units of the Company (the Units) of up to $10 million (the Offering).
  • The definitive size of the Offering, issue price per Unit and exercise price of each Warrant will be determined in the context of the market.
  • Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new set of proprietary platforms addressing renal replacement therapy (RRT) across the dialysis spectrum.
  • There can be no assurance that the Offering will be completed or as to the actual size or pricing of the Offering.

Quanta to Present at the LifeSci Partners Private Company Summer Symposium

Retrieved on: 
Monday, July 19, 2021

Headquartered in the UK and with operations inthe US, Quanta is a trans-Atlantic, commercial-stage medical technology innovator.

Key Points: 
  • Headquartered in the UK and with operations inthe US, Quanta is a trans-Atlantic, commercial-stage medical technology innovator.
  • Quantas lead product, SC+, is a small and simple, powerful hemodialysis system designed to providegreater freedom and flexibility in the delivery of life sustaining dialysis treatments.
  • The simple-to-use and digitally connected design of SC+ is intended to empower more patients to take control oftheir lives with selfcare and home dialysis.
  • Meanwhile, as a compact, portable and versatile device, SC+provides flexibility to deliver dialysis across a wide range of use environments and prescriptions.

Worldwide PTFE Membranes Industry to 2025 - Growing Demand for Water and Wastewater Treatment is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021

Based on Geography, the PTFE Membranes Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa.

Key Points: 
  • Based on Geography, the PTFE Membranes Market is examined across Americas, Asia-Pacific, and Europe, Middle East & Africa.
  • The Americas commanded the largest size in the PTFE Membranes Market in 2020.
  • What are the inhibiting factors and impact of COVID-19 shaping the Global PTFE Membranes Market during the forecast period?
  • What are the modes and strategic moves considered suitable for entering the Global PTFE Membranes Market?

Ambulnz Launches Service in Illinois

Retrieved on: 
Wednesday, July 14, 2021

With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.

Key Points: 
  • With this latest expansion, Ambulnz will be able to serve 9 Fresenius Kidney Care centers in Illinois, with plans to expand coverage to an additional 50 Chicago-area clinics in the coming months.
  • Ambulnz will assist people getting to and from scheduled dialysis appointments.
  • Dialysis patients in Illinois using Ambulnz services can now get dedicated and reliable transportation to and from their kidney dialysis appointments.
  • Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care.

Xenios AG receives approval in China for ECMO devices

Retrieved on: 
Tuesday, July 13, 2021

In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.

Key Points: 
  • In early May, Xenios AG, a Fresenius Medical Care company, received approval for two patient kits in China.
  • As a result, a complete Xenios system is now permitted for ECMO therapy in China.
  • This Xenios ECMO complete system is certified in China for nine days application period.
  • The expedited approval was a joint effort by Xenios and Fresenius Medical Care China Team.